4//SEC Filing
Shanley John F 4
Accession 0001181431-07-008139
CIK 0001108271other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:10 PM ET
Size
20.5 KB
Accession
0001181431-07-008139
Insider Transaction Report
Form 4
Shanley John F
DirectorChief Technology Officer
Transactions
- Disposition to Issuer
Common Stock
2007-02-01$33.50/sh−2,000$67,000→ 0 total - Disposition to Issuer
Employee Stock Option (Right to Buy)
2007-02-01$32.31/sh−315,000$10,177,650→ 0 totalExercise: $1.19Exp: 2014-08-11→ Common Stock (315,000 underlying) - Disposition to Issuer
Common Stock
2007-02-01$33.50/sh−54,600$1,829,100→ 0 total(indirect: See Footnote) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2007-02-01$11.46/sh−80,000$916,800→ 0 totalExercise: $22.04Exp: 2016-01-20→ Common Stock (80,000 underlying) - Disposition to Issuer
Common Stock
2007-02-01$33.50/sh−1,130,200$37,861,700→ 0 total(indirect: See Footnote) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2007-02-01$33.21/sh−157,500$5,230,575→ 0 totalExercise: $0.29Exp: 2013-11-18→ Common Stock (157,500 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2007-02-01$17.62/sh−60,000$1,057,200→ 0 totalExercise: $15.88Exp: 2015-05-09→ Common Stock (60,000 underlying)
Footnotes (6)
- [F1]Pursuant to the terms of the Agreement and Plan of Merger, dated November 16, 2006, among Conor Medsystems, Inc., Johnson & Johnson and Cypress Acquisition Sub, Inc., a wholly owned subsidiary of Johnson & Johnson (the "Merger Agreement"), each issued and outstanding share of common stock was automatically canceled and converted into the right to receive a per share amount equal to $33.50 in cash, without interest.
- [F2]Shares were held by the Shanley Family Trust dated September 10, 2004.
- [F3]Shares were held by the Conor E. Shanley Trust dated September 4, 2003.
- [F4]Shares were held by the John F. Shanley IV Trust dated September 4, 2003.
- [F5]Shares were held by the Ryan J. Shanley Trust dated September 4, 2003.
- [F6]This option, which vested in increments of one forty-eighth of the total shares subject to the option each month, was canceled pursuant to the terms of the Merger Agreement, in exchange for a cash payment equal to the excess of the $33.50 per share merger consideration over the per share exercise price of the option, multiplied by the number of shares of common stock subject to the option.
Documents
Issuer
CONOR MEDSYSTEMS INC
CIK 0001108271
Entity typeother
Related Parties
1- filerCIK 0001310733
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 5:10 PM ET
- Size
- 20.5 KB